The 4100 Group

Investment leadership is segmented by vertical. Ken Brodkowitz serves as CIO of 4100FS, the financial-services and multi-family-office arm, drawing on his experience as co-head of proprietary trading at Goldman Sachs and founder of Newland Capital Management. Scott Lancaster, an MD and former clinical director of Spectrum Health Ventures, is CIO and Managing Director of 4100DX, the healthcare venture platform. Mike Gilmore, as President and CEO, holds ultimate oversight across both divisions.

The firm leverages an elite network of strategic corporate relationships across the health and financial sectors, per its own materials. 4100DX draws on its leaders' clinical and venture operating backgrounds — Lancaster's tenure at Spectrum Health Ventures and McLean's at Corewell Health Ventures — to access healthcare innovation deal flow. 4100FS sources through the multi-family-office network and the institutional connections of its Goldman Sachs-alumni investment team.

It operates as a hybrid. The group is organized around a patient-capital vehicle with an infinite time horizon, a hallmark of single-family-office structures, but it fields dedicated managing principals and CIOs for financial services and healthcare — a configuration that mirrors a sector-focused investment firm. Its 4100DX arm makes venture-stage healthcare investments, while 4100FS acquires and builds financial-services companies, a blend that distinguishes it from both pure family offices and traditional venture firms.

The firm's materials indicate a focus on direct strategic investments and acquisitions. 4100FS owns portfolio companies such as Gries Financial Partners and Bull Harbor Capital outright. 4100DX takes board seats in its healthcare ventures, including Sensory Cloud, Joyn Health, and Orbita. The firm describes its capital solutions as forming strategic alliances, which suggests direct and co-investment activity rather than passive fund commitments.

The group invests across all development phases, according to its website. 4100FS targets client-facing and client-supporting financial-services businesses at various stages, from early growth through mature operating companies. 4100DX's healthcare fund focuses on nurturing innovative companies, implying venture- and growth-stage activity, particularly in dental and oral-care innovation for its inaugural vehicle.

The group does not publish an explicit avoidance list. Its stated focus is confined to financial services — particularly wealth management, multi-family office services, asset management, and complementary financial services — and healthcare, including care delivery, therapeutics, and medical technologies. Sectors outside these two verticals appear absent from its disclosed strategy.

Mike Gilmore, the group's President and CEO, concurrently serves as President and CEO of Red Cedar Investment Management. The relationship is not publicly detailed beyond Gilmore's dual role, and Red Cedar is not listed as a formal subsidiary of The 4100 Group. Mike Davidson, the group's Chief Administrative Officer, previously held technology and CAO roles at Red Cedar, indicating overlapping leadership and operational DNA.